Total Payments
$39,505
2024 Payments
$5,330
Companies
78
Transactions
2,417
Medicare Patients
27,740
Medicare Billing
$12.9M
Payment Breakdown by Category
Food & Beverage$37,393 (94.7%)
Consulting$1,463 (3.7%)
Education$601.40 (1.5%)
Travel$48.14 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $37,393 | 2,397 | 94.7% |
| Consulting Fee | $1,463 | 1 | 3.7% |
| Education | $601.40 | 16 | 1.5% |
| Travel and Lodging | $48.14 | 2 | 0.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$39,505
2,416 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $6,680 | 428 | $0 (2024) |
| ABBVIE INC. | $4,474 | 208 | $0 (2024) |
| Janssen Biotech, Inc. | $2,591 | 207 | $0 (2024) |
| PFIZER INC. | $2,484 | 254 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,287 | 125 | $0 (2024) |
| UCB, Inc. | $1,762 | 126 | $0 (2024) |
| Genentech USA, Inc. | $1,745 | 119 | $0 (2024) |
| Cardinal Health 108, LLC | $1,561 | 4 | $0 (2017) |
| Lilly USA, LLC | $1,435 | 110 | $0 (2024) |
| Horizon Therapeutics plc | $1,130 | 75 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,330 | 280 | Amgen Inc. ($751.36) |
| 2023 | $5,126 | 290 | Amgen Inc. ($735.10) |
| 2022 | $5,520 | 304 | Amgen Inc. ($931.10) |
| 2021 | $4,208 | 243 | Amgen Inc. ($901.18) |
| 2020 | $3,050 | 198 | Amgen Inc. ($1,015) |
| 2019 | $4,977 | 336 | Amgen Inc. ($1,215) |
| 2018 | $5,190 | 390 | Amgen Inc. ($559.97) |
| 2017 | $6,103 | 376 | Cardinal Health 108, LLC ($1,561) |
All Payment Transactions
2,417 individual payment records from CMS Open Payments — Page 1 of 97
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Opioid Analgesic | ||||||
| 12/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | SCILEX PHARMACEUTICALS INC. | GLOPERBA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Analgesic | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/06/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 76 | 6,787 | 232,266 | $9.5M | $3.1M |
| 2022 | 75 | 7,769 | 204,517 | $9.1M | $3.4M |
| 2021 | 77 | 7,332 | 162,065 | $7.9M | $3.2M |
| 2020 | 70 | 5,852 | 162,509 | $7.5M | $3.1M |
Total Patients
27,740
Total Services
761,357
Medicare Billing
$12.9M
Procedure Codes
298
All Medicare Procedures & Services
298 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 38 | 23,035 | $1.7M | $774,005 | 46.6% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 36 | 10,909 | $1.4M | $674,275 | 49.6% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 32 | 123,657 | $1.9M | $578,583 | 29.8% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 34 | 32,172 | $1.3M | $327,927 | 24.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 26 | 7,584 | $988,000 | $198,428 | 20.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 71 | 6,364 | $200,940 | $116,240 | 57.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 566 | 1,259 | $371,503 | $107,477 | 28.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 118 | 714 | $223,606 | $69,647 | 31.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 143 | 597 | $174,848 | $28,342 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 309 | 444 | $76,068 | $26,222 | 34.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 219 | 472 | $73,416 | $23,357 | 31.8% |
| 86481 | Tuberculosis test, enumeration of t-cells | Office | 2023 | 144 | 150 | $30,376 | $14,700 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $40,710 | $13,490 | 33.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 74 | 550 | $118,698 | $11,665 | 9.8% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 178 | 289 | $39,782 | $8,817 | 22.2% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 183 | 297 | $40,421 | $8,143 | 20.1% |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | Office | 2023 | 12 | 601 | $12,900 | $7,125 | 55.2% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 56 | 399 | $34,335 | $7,011 | 20.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 167 | 271 | $37,775 | $6,982 | 18.5% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2023 | 26 | 13,146 | $52,584 | $6,899 | 13.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 467 | 831 | $74,173 | $6,322 | 8.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 53 | 270 | $30,966 | $5,910 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 399 | 682 | $7,785 | $5,721 | 73.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 151 | 151 | $38,430 | $5,448 | 14.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 73 | 408 | $50,294 | $4,759 | 9.5% |
About Dr. Bob Wodecki, MD
Dr. Bob Wodecki, MD is a Internal Medicine healthcare provider based in Statesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649270190.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bob Wodecki, MD has received a total of $39,505 in payments from pharmaceutical and medical device companies, with $5,330 received in 2024. These payments were reported across 2,417 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($37,393).
As a Medicare-enrolled provider, Wodecki has provided services to 27,740 Medicare beneficiaries, totaling 761,357 services with total Medicare billing of $12.9M. Data is available for 4 years (2020–2023), covering 298 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Statesville, NC
- Active Since 07/27/2005
- Last Updated 01/08/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649270190
Products in Payments
- Enbrel (Biological) $4,367
- RINVOQ (Biological) $1,823
- Cimzia (Drug) $1,721
- XELJANZ (Drug) $1,610
- COSENTYX (Biological) $1,474
- TREMFYA (Drug) $1,294
- PURIFIED CORTROPHIN GEL (Drug) $1,193
- TALTZ (Drug) $1,176
- Rituxan (Biological) $1,160
- ACTHAR (Biological) $1,148
- KRYSTEXXA (Biological) $1,061
- BENLYSTA (Biological) $1,057
- ORENCIA (Biological) $1,031
- SIMPONI ARIA (Biological) $1,030
- Humira (Biological) $990.79
- EVENITY (Biological) $985.31
- SAPHNELO (Biological) $815.87
- COSENTYX (Drug) $668.76
- KEVZARA (Biological) $656.12
- SKYRIZI (Biological) $628.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Statesville
Mr. Menelaos Voulgaropoulos, M.d, M.D
Internal Medicine — Payments: $71,910
Internal Medicine $71,910
Joseph Moran, M.d, M.D
Internal Medicine — Payments: $37,250
Internal Medicine $37,250
William White, Md, MD
Internal Medicine — Payments: $18,470
Internal Medicine $18,470
Debra Szostak-Wodecki, Md, MD
Internal Medicine — Payments: $14,967
Internal Medicine $14,967
Anita Misra, M.d, M.D
Internal Medicine — Payments: $11,249
Internal Medicine $11,249
John Nicholson, Md, MD
Internal Medicine — Payments: $8,900
Internal Medicine $8,900